NCT06307431 · Active not recruiting
A Study of Adjuvant Intismeran Autogene (V940) and Pembrolizumab in Renal Cell Carcinoma (V940-004).

Start your clinical trial request

Sign in to choose who this request is for, add supporting documents, and send it to our clinical team.

Your request is reviewed and a WeTrials Clinical Navigator will contact you in 1–2 business days. Your profiles and documents stay private to you.

New to WeTrials? Continuing creates your account.